Profiel
Scott A. Byrd is Chief Executive Officer & Director at Sudo Biosciences, Inc. since 2021.
Mr. Byrd is Independent Chairman at Acacia Pharma Group Ltd. since 2015.
Mr. Byrd is Non-Executive Director at Acacia Pharma Ltd. Mr. Byrd is Independent Director at AlgoTherapeutix SAS. Formerly, Mr. Byrd was President, CEO, Secretary & Treasurer at Outpost Medicine, Inc. Mr. Byrd was President & Chief Executive Officer at Outpost Medicine Ltd. from 2017 to 2023.
Mr. Byrd was Senior Director-Global Brands at Eli Lilly & Co. from 1992 to 2006.
Mr. Byrd was Chief Commercial Officer & Senior Vice President at Mallinckrodt Hospital Products, Inc. from 2009 to 2014.
Mr. Byrd was President & Chief Operating Officer at Acacia Pharma, Inc. from 2009 to 2014.
Education includes undergraduate degree from Bradley University and MBA from Harvard Business School.
Actieve functies van Scott Byrd
| Bedrijven | Functie | Begin |
|---|---|---|
| ACACIA PHARMA GROUP PLC | Voorzitter | 02-03-2020 |
Acacia Pharma Ltd.
Acacia Pharma Ltd. Pharmaceuticals: MajorHealth Technology Provides supportive care product opportunities for post-surgical and cancer patients | Directeur/Bestuurslid | - |
Algotherapeutix SAS
Algotherapeutix SAS Medical SpecialtiesHealth Technology Manufactures clinical supplies | Directeur/Bestuurslid | - |
Sudo Biosciences, Inc.
Sudo Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that designs and develops medicines that target the tyrosine kinase | Algemeen Directeur | 01-04-2021 |
Eerdere bekende functies van Scott Byrd
| Bedrijven | Functie | Einde |
|---|---|---|
Outpost Medicine Ltd.
Outpost Medicine Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Algemeen Directeur | 05-09-2023 |
| CADENCE PHARMACEUTICALS, INC. | Corporate Officer/Principal | 19-03-2014 |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | - |
Outpost Medicine, Inc.
Outpost Medicine, Inc. Pharmaceuticals: MajorHealth Technology Engages in drug development activities | Algemeen Directeur | - |
Acacia Pharma, Inc.
Acacia Pharma, Inc. Medical DistributorsDistribution Services Distributes pharmaceutical products | President | 01-01-2014 |
Opleiding van Scott Byrd
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 11 |
|---|---|
Eli Lilly & Co.
Eli Lilly & Co. Pharmaceuticals: MajorHealth Technology Manufactures, wholesales and markets pharmaceutical products | Health Technology |
Bradley University
Bradley University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Mallinckrodt Hospital Products, Inc.
Mallinckrodt Hospital Products, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Acacia Pharma Ltd.
Acacia Pharma Ltd. Pharmaceuticals: MajorHealth Technology Provides supportive care product opportunities for post-surgical and cancer patients | Health Technology |
Harvard Business School
Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Acacia Pharma Group Ltd.
Acacia Pharma Group Ltd. Pharmaceuticals: MajorHealth Technology Operates as a holding company that engages in developing and commercializing novel products for surgery, invasive procedures & chemotherapy | Health Technology |
Acacia Pharma, Inc.
Acacia Pharma, Inc. Medical DistributorsDistribution Services Distributes pharmaceutical products | Distribution Services |
Outpost Medicine, Inc.
Outpost Medicine, Inc. Pharmaceuticals: MajorHealth Technology Engages in drug development activities | Health Technology |
Outpost Medicine Ltd.
Outpost Medicine Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Algotherapeutix SAS
Algotherapeutix SAS Medical SpecialtiesHealth Technology Manufactures clinical supplies | Health Technology |
Sudo Biosciences, Inc.
Sudo Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that designs and develops medicines that target the tyrosine kinase | Health Technology |
















